Titan Pharmaceuticals, Inc. (TTNP) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TTNP Revenue Growth
Revenue Breakdown (FY 2023)
TTNP's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
TTNP Revenue Analysis (2013–2024)
As of May 8, 2026, Titan Pharmaceuticals, Inc. (TTNP) generated trailing twelve-month (TTM) revenue of $10,000. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, TTNP's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $15.1 million in 2016.
Revenue diversification analysis shows TTNP's business is primarily driven by Grant (99%), and License and Service (1%). With over half of revenue concentrated in Grant, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), MTLS (+4.4% YoY), and AVDL (+79.9% YoY). Compare TTNP vs NKTR →
TTNP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TTNPCurrent | $10,000 | - | - | - | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 MTLS | $257M | +4.4% | +8.6% | 1.9% | |
 AVDL | $169M | +79.9% | +23.4% | -25.1% | |
 COLL | $781M | +19.9% | +20.3% | 24.0% |
TTNP Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | -100.0% | $-5,000 | - | $-4,557,000 | - |
| 2023 | $1K | -98.3% | $1K | 100.0% | $-7,277,000 | -727700.0% |
| 2022 | $60K | -96.1% | $-136,000 | -226.7% | $-10,235,000 | -17058.3% |
| 2021 | $1.5M | -68.5% | $1.3M | 87.0% | $-9,354,000 | -613.0% |
| 2020 | $4.8M | +34.0% | $4.4M | 90.2% | $-7,351,000 | -151.9% |
| 2019 | $3.6M | -38.9% | $2.3M | 64.3% | $-16,844,000 | -466.5% |
| 2018 | $5.9M | +2649.3% | $5.4M | 90.9% | $-8,264,000 | -139.8% |
| 2017 | $215K | -98.6% | $-9,433,000 | -4387.4% | $-14,502,000 | -6745.1% |
| 2016 | $15.1M | +801.6% | $8.9M | 59.3% | $4.3M | 28.8% |
| 2015 | $1.7M | -54.2% | $-3,004,000 | -179.8% | $-6,759,000 | -404.5% |
See TTNP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TTNP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TTNP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTTNP — Frequently Asked Questions
Quick answers to the most common questions about buying TTNP stock.
Is TTNP's revenue growth accelerating or slowing?
TTNP TTM revenue: $10000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TTNP's long-term revenue growth rate?
Titan Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TTNP's revenue distributed by segment?
TTNP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.